Get the Stockscreener App
1.8531
3.12%
-0.0669
Tiziana Life Sciences Ltd stock is traded at $1.8531, with a volume of 43,352.
It is down -3.12% in the last 24 hours and down -5.58% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
See More
Previous Close:
$1.92
Open:
$1.93
24h Volume:
43,352
Relative Volume:
0.11
Market Cap:
$216.53M
Revenue:
-
Net Income/Loss:
$-13.73M
P/E Ratio:
-14.25
EPS:
-0.13
Net Cash Flow:
$-3.92M
1W Performance:
-1.59%
1M Performance:
-5.58%
6M Performance:
+45.31%
1Y Performance:
+98.44%
1-Day Range:
$1.8531
$1.9506
1-Week Range:
$1.78
$2.10
52-Week Range:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.8531 | 228.14M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.96 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.74 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.26 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Is Tiziana Life Sciences Ltd stock a buy before product launchesInsider Selling & Stock Portfolio Risk Management - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
What technical signals suggest for Tiziana Life Sciences Ltd stockEarnings Risk Report & Consistent Growth Equity Picks - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investors2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Is Tiziana Life Sciences Ltd stock recession proof2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryEarnings Summary Report & Community Trade Idea Sharing - newser.com
Applying big data sentiment scoring on Tiziana Life Sciences LtdRate Cut & Verified Momentum Watchlists - newser.com
Can momentum traders help lift Tiziana Life Sciences LtdMarket Rally & Verified Momentum Stock Watchlist - newser.com
How to use a screener to detect Tiziana Life Sciences Ltd breakoutsMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exit2025 Risk Factors & High Win Rate Trade Alerts - newser.com
How to manage a losing position in Tiziana Life Sciences Ltd2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
How Tiziana Life Sciences Ltd stock valuations compare to rivals2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketWeekly Investment Report & Fast Gain Stock Tips - newser.com
Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha
Published on: 2025-10-31 05:15:32 - newser.com
Reversal indicators forming on Tiziana Life Sciences Ltd stockTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy - The Manila Times
Tiziana (Nasdaq: TLSA) to present at BIO-Europe on intranasal foralumab for na‑SPMS, MSA - Stock Titan
Tiziana Life Sciences to showcase intranasal foralumab at BIO-Europe 2025 - Proactive financial news
What hedge fund activity signals for Tiziana Life Sciences Ltd stockLong Setup & AI Forecasted Entry/Exit Points - newser.com
How Tiziana Life Sciences Ltd stock trades during market volatilityJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Has Tiziana Life Sciences Ltd found a price floorPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
How supply chain issues affect Tiziana Life Sciences Ltd stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - fcp.pa.gov.br
Is Tiziana Life Sciences Ltd stock attractive after correctionJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):